{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:29:32Z","timestamp":1793860172090,"version":"4.6.1"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2023AFC017"],"award-info":[{"award-number":["2023AFC017"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11707-y","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:51:15Z","timestamp":1787932275000},"page":"9453-9475","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Natural products mediate ferroptosis and immune microenvironment-linked sensitization in osteosarcoma: from chemotherapy resistance to combined therapeutic transformation"],"prefix":"10.1007","volume":"30","author":[{"given":"Yuwen","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"issue":"1","key":"11707_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41572-022-00409-y","volume":"8","author":"HC Beird","year":"2022","unstructured":"Beird HC, Bielack SS, Flanagan AM et al (2022) Osteosarcoma. Nat Rev Dis Primers 8(1):77. https:\/\/doi.org\/10.1038\/s41572-022-00409-y","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"11707_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41571-021-00519-8","volume":"18","author":"J Gill","year":"2021","unstructured":"Gill J, Gorlick R (2021) Advancing therapy for osteosarcoma. Nat Rev Clin Oncol 18(10):609\u2013624. https:\/\/doi.org\/10.1038\/s41571-021-00519-8","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"11707_CR3","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1002\/cncr.34163","volume":"128","author":"S Cole","year":"2022","unstructured":"Cole S, Gianferante DM, Zhu B, Mirabello L (2022) Osteosarcoma: A Surveillance, Epidemiology, and End Results program-based analysis from 1975 to 2017. Cancer 128(11):2107\u20132118. https:\/\/doi.org\/10.1002\/cncr.34163","journal-title":"Cancer"},{"issue":"4","key":"11707_CR4","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/os.13243","volume":"14","author":"G Xu","year":"2022","unstructured":"Xu G, Wu H, Zhang Y et al (2022) Risk and Prognostic Factors for Different Organ Metastasis in Primary Osteosarcoma: A Large Population-Based Analysis. Orthop Surg 14(4):714\u2013719. https:\/\/doi.org\/10.1111\/os.13243","journal-title":"Orthop Surg"},{"issue":"1","key":"11707_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41413-024-00359-z","volume":"12","author":"RA Lacinski","year":"2024","unstructured":"Lacinski RA, Dziadowicz SA, Melemai VK et al (2024) Spatial multiplexed immunofluorescence analysis reveals coordinated cellular networks associated with overall survival in metastatic osteosarcoma. Bone Res 12(1):55. https:\/\/doi.org\/10.1038\/s41413-024-00359-z","journal-title":"Bone Res"},{"issue":"5","key":"11707_CR6","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.3390\/cimb45050276","volume":"45","author":"I Urli\u0107","year":"2023","unstructured":"Urli\u0107 I, Jovi\u010di\u0107 M, Ostoji\u0107 K, Ivkovi\u0107 A (2023) Cellular and Genetic Background of Osteosarcoma. Curr Issues Mol Biol 45(5):4344\u20134358. https:\/\/doi.org\/10.3390\/cimb45050276","journal-title":"Curr Issues Mol Biol"},{"issue":"6","key":"11707_CR7","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1093\/annonc\/mdn731","volume":"20","author":"AH Aljubran","year":"2009","unstructured":"Aljubran AH, Griffin A, Pintilie M, Blackstein M (2009) Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases. Ann Oncol 20(6):1136\u20131141. https:\/\/doi.org\/10.1093\/annonc\/mdn731","journal-title":"Ann Oncol"},{"key":"11707_CR8","doi-asserted-by":"publisher","unstructured":"Biermann JS, Hirbe A, Ahlawat S et al. Bone Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw 2025;23(4) https:\/\/doi.org\/10.6004\/jnccn.2025.0017","DOI":"10.6004\/jnccn.2025.0017"},{"issue":"6","key":"11707_CR9","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1080\/15548627.2022.2150003","volume":"19","author":"J Niu","year":"2023","unstructured":"Niu J, Yan T, Guo W et al (2023) The COPS3-FOXO3 positive feedback loop regulates autophagy to promote cisplatin resistance in osteosarcoma. Autophagy 19(6):1693\u20131710. https:\/\/doi.org\/10.1080\/15548627.2022.2150003","journal-title":"Autophagy"},{"key":"11707_CR10","doi-asserted-by":"publisher","first-page":"1588302","DOI":"10.3389\/fmed.2025.1588302","volume":"12","author":"T Kanthawang","year":"2025","unstructured":"Kanthawang T, Pattamapaspong N, Settakorn J et al (2025) Development and validation of a predictive score for chemoresistance in high-grade osteosarcoma at baseline. Front Med (Lausanne) 12:1588302. https:\/\/doi.org\/10.3389\/fmed.2025.1588302","journal-title":"Front Med (Lausanne)"},{"key":"11707_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bbrc.2021.02.137","volume":"550","author":"M Chen","year":"2021","unstructured":"Chen M, Jiang Y, Sun Y (2021) KDM4A-mediated histone demethylation of SLC7A11 inhibits cell ferroptosis in osteosarcoma. Biochem Biophys Res Commun 550:77\u201383. https:\/\/doi.org\/10.1016\/j.bbrc.2021.02.137","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"11707_CR12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41388-023-02882-5","volume":"43","author":"M He","year":"2024","unstructured":"He M, Wang Y, Xie J et al (2024) M(7)G modification of FTH1 and pri-miR-26a regulates ferroptosis and chemotherapy resistance in osteosarcoma. Oncogene 43(5):341\u2013353. https:\/\/doi.org\/10.1038\/s41388-023-02882-5","journal-title":"Oncogene"},{"key":"11707_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.freeradbiomed.2026.03.046","volume":"249","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, Meng T, Chen L et al (2026) METTL3-mediated m6A modification contributes to anlotinib resistance in osteosarcoma by regulating ferroptosis via the circFAM120B\/miR-330-3p\/PRKDC axis. Free Radic Biol Med 249:409\u2013423. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2026.03.046","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"11707_CR14","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41417-022-00581-z","volume":"30","author":"L Li","year":"2023","unstructured":"Li L, Zhang Y, Gao Y et al (2023) LncSNHG14 promotes nutlin3a resistance by inhibiting ferroptosis via the miR-206 \/SLC7A11 axis in osteosarcoma cells. Cancer Gene Ther 30(5):704\u2013715. https:\/\/doi.org\/10.1038\/s41417-022-00581-z","journal-title":"Cancer Gene Ther"},{"issue":"11","key":"11707_CR15","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/cbin.11121","volume":"43","author":"Q Liu","year":"2019","unstructured":"Liu Q, Wang K (2019) The induction of ferroptosis by impairing STAT3\/Nrf2\/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin. Cell Biol Int 43(11):1245\u20131256. https:\/\/doi.org\/10.1002\/cbin.11121","journal-title":"Cell Biol Int"},{"key":"11707_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2026.102860","volume":"71","author":"J Hu","year":"2026","unstructured":"Hu J, Huang Y, Chen H et al (2026) PYCR1 induces ferroptosis via the PI3K\/Akt signaling pathway to regulate the proliferation and migration of osteosarcoma. Transl Oncol 71:102860. https:\/\/doi.org\/10.1016\/j.tranon.2026.102860","journal-title":"Transl Oncol"},{"issue":"2","key":"11707_CR17","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.cell.2024.12.005","volume":"188","author":"J Espejo Valle-Inclan","year":"2025","unstructured":"Espejo Valle-Inclan J, De Noon S, Trevers K et al (2025) Ongoing chromothripsis underpins osteosarcoma genome complexity and clonal evolution. Cell 188(2):352-370.e322. https:\/\/doi.org\/10.1016\/j.cell.2024.12.005","journal-title":"Cell"},{"issue":"1","key":"11707_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02129-1","volume":"21","author":"W Chen","year":"2023","unstructured":"Chen W, Li Z, Yu N et al (2023) Bone-targeting exosome nanoparticles activate Keap1 \/ Nrf2 \/ GPX4 signaling pathway to induce ferroptosis in osteosarcoma cells. J Nanobiotechnol 21(1):355. https:\/\/doi.org\/10.1186\/s12951-023-02129-1","journal-title":"J Nanobiotechnol"},{"issue":"7","key":"11707_CR19","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1158\/0008-5472.Can-23-1307","volume":"84","author":"Y Xu","year":"2024","unstructured":"Xu Y, Deng C, Chen H et al (2024) Osteosarcoma cells secrete CXCL14 that activates integrin \u03b111\u03b21 on fibroblasts to form a lung metastatic niche. Cancer Res 84(7):994\u20131012. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-1307","journal-title":"Cancer Res"},{"issue":"11","key":"11707_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07168-6","volume":"15","author":"S Wang","year":"2024","unstructured":"Wang S, Nie J, Jiang H et al (2024) VCP enhances autophagy-related osteosarcoma progression by recruiting USP2 to inhibit ubiquitination and degradation of FASN. Cell Death Dis 15(11):788. https:\/\/doi.org\/10.1038\/s41419-024-07168-6","journal-title":"Cell Death Dis"},{"issue":"13","key":"11707_CR21","doi-asserted-by":"publisher","first-page":"5162","DOI":"10.7150\/ijbs.100015","volume":"20","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Pan R, Li K et al (2024) HSPD1 supports osteosarcoma progression through stabilizing ATP5A1 and thus activation of AKT\/mTOR signaling. Int J Biol Sci 20(13):5162\u20135190. https:\/\/doi.org\/10.7150\/ijbs.100015","journal-title":"Int J Biol Sci"},{"issue":"1","key":"11707_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01804-z","volume":"22","author":"M Jiang","year":"2023","unstructured":"Jiang M, Jike Y, Liu K et al (2023) Exosome-mediated miR-144-3p promotes ferroptosis to inhibit osteosarcoma proliferation, migration, and invasion through regulating ZEB1. Mol Cancer 22(1):113. https:\/\/doi.org\/10.1186\/s12943-023-01804-z","journal-title":"Mol Cancer"},{"issue":"14","key":"11707_CR23","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR (2022) Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell 185(14):2401\u20132421. https:\/\/doi.org\/10.1016\/j.cell.2022.06.003","journal-title":"Cell"},{"issue":"9","key":"11707_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2025.101228","volume":"15","author":"S Qin","year":"2025","unstructured":"Qin S, Kong H, Jiang L (2025) ZFP36 promotes ferroptosis and mitochondrial dysfunction and inhibits malignant progression in osteosarcoma by regulating the E2F1\/ATF4 axis. J Pharm Anal 15(9):101228. https:\/\/doi.org\/10.1016\/j.jpha.2025.101228","journal-title":"J Pharm Anal"},{"key":"11707_CR25","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jare.2025.06.022","volume":"81","author":"M Zhang","year":"2026","unstructured":"Zhang M, Wang Q, Li C et al (2026) Ion interference induced by Ca-Mn nanoplatform enhances ferroptosis and promotes immune response for osteosarcoma treatment. J Adv Res 81:823\u2013836. https:\/\/doi.org\/10.1016\/j.jare.2025.06.022","journal-title":"J Adv Res"},{"issue":"1","key":"11707_CR26","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s12951-025-03380-4","volume":"23","author":"T Xu","year":"2025","unstructured":"Xu T, Ma Q, Zhang C et al (2025) A novel nanomedicine for osteosarcoma treatment: triggering ferroptosis through GSH depletion and inhibition for enhanced synergistic PDT\/PTT therapy. J Nanobiotechnology 23(1):323. https:\/\/doi.org\/10.1186\/s12951-025-03380-4","journal-title":"J Nanobiotechnology"},{"key":"11707_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112257","volume":"144","author":"M Tobeiha","year":"2021","unstructured":"Tobeiha M, Rajabi A, Raisi A et al (2021) Potential of natural products in osteosarcoma treatment: Focus on molecular mechanisms. Biomed Pharmacother 144:112257. https:\/\/doi.org\/10.1016\/j.biopha.2021.112257","journal-title":"Biomed Pharmacother"},{"key":"11707_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5192271","author":"Z Tang","year":"2021","unstructured":"Tang Z, Dong H, Li T et al (2021) The synergistic reducing drug resistance effect of cisplatin and ursolic acid on osteosarcoma through a multistep mechanism involving ferritinophagy. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2021\/5192271","journal-title":"Oxid Med Cell Longev"},{"key":"11707_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108572","volume":"161","author":"D Duan","year":"2025","unstructured":"Duan D, Yang X, Guo X et al (2025) Interaction of glaucocalyxin a with glutathione and thioredoxin reductase for triple-negative breast cancer treatment. Bioorg Chem 161:108572. https:\/\/doi.org\/10.1016\/j.bioorg.2025.108572","journal-title":"Bioorg Chem"},{"key":"11707_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26061666","author":"X Gao","year":"2021","unstructured":"Gao X, Zhang C, Wang Y et al (2021) Berberine and cisplatin exhibit synergistic anticancer effects on osteosarcoma MG-63 cells by inhibiting the MAPK pathway. Molecules. https:\/\/doi.org\/10.3390\/molecules26061666","journal-title":"Molecules"},{"key":"11707_CR31","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.2147\/ijn.S398046","volume":"18","author":"WT Zhu","year":"2023","unstructured":"Zhu WT, Zeng XF, Yang H et al (2023) Resveratrol Loaded by Folate-Modified Liposomes Inhibits Osteosarcoma Growth and Lung Metastasis via Regulating JAK2\/STAT3 Pathway. Int J Nanomed 18:2677\u20132691. https:\/\/doi.org\/10.2147\/ijn.S398046","journal-title":"Int J Nanomed"},{"key":"11707_CR32","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2024.5635","author":"M Song","year":"2024","unstructured":"Song M, Tian X, Lu M et al (2024) Corrigendum] Genistein exerts growth inhibition on human osteosarcoma MG-63 cells via PPAR\u03b3 pathway. Int J Oncol. https:\/\/doi.org\/10.3892\/ijo.2024.5635","journal-title":"Int J Oncol"},{"issue":"5","key":"11707_CR33","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1002\/ptr.8146","volume":"38","author":"H Wu","year":"2024","unstructured":"Wu H, Ma T, He M et al (2024) Cucurbitacin B modulates M2 macrophage differentiation and attenuates osteosarcoma progression via PI3K\/AKT pathway. Phytother Res 38(5):2215\u20132233. https:\/\/doi.org\/10.1002\/ptr.8146","journal-title":"Phytother Res"},{"issue":"2","key":"11707_CR34","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jhep.2023.03.016","volume":"79","author":"F He","year":"2023","unstructured":"He F, Zhang P, Liu J et al (2023) ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis. J Hepatol 79(2):362\u2013377. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.016","journal-title":"J Hepatol"},{"key":"11707_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156960","volume":"145","author":"Y Liu","year":"2025","unstructured":"Liu Y, Xie T, Liang J et al (2025) Formononetin enhances cisplatin chemotherapy sensitivity in osteosarcoma by inducing ferroptosis and reconstructing the immune microenvironment. Phytomedicine 145:156960. https:\/\/doi.org\/10.1016\/j.phymed.2025.156960","journal-title":"Phytomedicine"},{"issue":"1","key":"11707_CR36","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/s41467-025-56456-y","volume":"16","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Zeng L, Cai L et al (2025) Cellular senescence-associated gene IFI16 promotes HMOX1-dependent evasion of ferroptosis and radioresistance in glioblastoma. Nat Commun 16(1):1212. https:\/\/doi.org\/10.1038\/s41467-025-56456-y","journal-title":"Nat Commun"},{"issue":"5","key":"11707_CR37","doi-asserted-by":"publisher","first-page":"899","DOI":"10.32604\/or.2023.042604","volume":"32","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Yang L, Yu Y et al (2024) Hydroxysafflor yellow A induced ferroptosis of Osteosarcoma cancer cells by HIF-1\u03b1\/HK2 and SLC7A11 pathway. Oncol Res 32(5):899\u2013910. https:\/\/doi.org\/10.32604\/or.2023.042604","journal-title":"Oncol Res"},{"key":"11707_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116346","volume":"226","author":"H Jiwa","year":"2024","unstructured":"Jiwa H, Xie Z, Qu X et al (2024) Casticin induces ferroptosis in human osteosarcoma cells through Fe(2+) overload and ROS production mediated by HMOX1 and LC3-NCOA4. Biochem Pharmacol 226:116346. https:\/\/doi.org\/10.1016\/j.bcp.2024.116346","journal-title":"Biochem Pharmacol"},{"key":"11707_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2024.100657","volume":"50","author":"Y Li","year":"2025","unstructured":"Li Y, Bai X (2025) Naringenin induces ferroptosis in osteosarcoma cells through the STAT3-MGST2 signaling pathway. J Bone Oncol 50:100657. https:\/\/doi.org\/10.1016\/j.jbo.2024.100657","journal-title":"J Bone Oncol"},{"key":"11707_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154881","volume":"116","author":"RJ Wen","year":"2023","unstructured":"Wen RJ, Dong X, Zhuang HW et al (2023) Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2\/xCT\/GPX4 regulatory axis. Phytomedicine 116:154881. https:\/\/doi.org\/10.1016\/j.phymed.2023.154881","journal-title":"Phytomedicine"},{"key":"11707_CR41","doi-asserted-by":"publisher","first-page":"8966368","DOI":"10.1155\/2022\/8966368","volume":"2022","author":"T He","year":"2022","unstructured":"He T, Lin X, Yang C et al (2022) Theaflavin-3,3\u2019-Digallate Plays a ROS-Mediated Dual Role in Ferroptosis and Apoptosis via the MAPK Pathway in Human Osteosarcoma Cell Lines and Xenografts. Oxid Med Cell Longev 2022:8966368. https:\/\/doi.org\/10.1155\/2022\/8966368","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"11707_CR42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12951-025-03206-3","volume":"23","author":"Z Lin","year":"2025","unstructured":"Lin Z, Li Y, Wu Z et al (2025) Eriodictyol-cisplatin coated nanomedicine synergistically promote osteosarcoma cells ferroptosis and chemosensitivity. J Nanobiotechnology 23(1):109. https:\/\/doi.org\/10.1186\/s12951-025-03206-3","journal-title":"J Nanobiotechnology"},{"key":"11707_CR43","doi-asserted-by":"publisher","first-page":"1783485","DOI":"10.1155\/2021\/1783485","volume":"2021","author":"Y Luo","year":"2021","unstructured":"Luo Y, Gao X, Zou L et al (2021) Bavachin Induces Ferroptosis through the STAT3\/P53\/SLC7A11 Axis in Osteosarcoma Cells. Oxid Med Cell Longev 2021:1783485. https:\/\/doi.org\/10.1155\/2021\/1783485","journal-title":"Oxid Med Cell Longev"},{"key":"11707_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157584","volume":"150","author":"S Wang","year":"2026","unstructured":"Wang S, Liang F, Wei H et al (2026) Licochalcone B targets neural cell adhesion molecule 1 to inhibit osteosarcoma progression and ferroptosis resistance via extracellular signal-regulated kinase 5 and nuclear factor kappa B pathways. Phytomedicine 150:157584. https:\/\/doi.org\/10.1016\/j.phymed.2025.157584","journal-title":"Phytomedicine"},{"key":"11707_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156139","volume":"135","author":"C Lu","year":"2024","unstructured":"Lu C, Zhang Z, Fan Y et al (2024) Shikonin induces ferroptosis in osteosarcomas through the mitochondrial ROS-regulated HIF-1\u03b1\/HO-1 axis. Phytomedicine 135:156139. https:\/\/doi.org\/10.1016\/j.phymed.2024.156139","journal-title":"Phytomedicine"},{"key":"11707_CR46","doi-asserted-by":"publisher","first-page":"1490759","DOI":"10.3389\/fphar.2024.1490759","volume":"15","author":"R Huang","year":"2024","unstructured":"Huang R, Chu D, Shi J et al (2024) Shikonin suppresses proliferation of osteosarcoma cells by inducing ferroptosis through promoting Nrf2 ubiquitination and inhibiting the xCT\/GPX4 regulatory axis. Front Pharmacol 15:1490759. https:\/\/doi.org\/10.3389\/fphar.2024.1490759","journal-title":"Front Pharmacol"},{"key":"11707_CR47","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2025.13765","author":"JY Chen","year":"2026","unstructured":"Chen JY, Wang GS, Chang TM, Liu JF (2026) Acetylshikonin induces ferroptosis via the lipid peroxidation pathway in osteosarcoma cells. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2025.13765","journal-title":"Mol Med Rep"},{"issue":"1","key":"11707_CR48","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1186\/s12967-025-07358-6","volume":"23","author":"M He","year":"2025","unstructured":"He M, Liu Y, Li T et al (2025) Machine learning-powered discovery of a novel berberine derivative inducing SCD-dependent ferroptosis in osteosarcoma. J Transl Med 23(1):1328. https:\/\/doi.org\/10.1186\/s12967-025-07358-6","journal-title":"J Transl Med"},{"issue":"26","key":"11707_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202306916","volume":"20","author":"Y Wang","year":"2024","unstructured":"Wang Y, Zhou X, Yao L et al (2024) Capsaicin Enhanced the Efficacy of Photodynamic Therapy Against Osteosarcoma via a Pro-Death Strategy by Inducing Ferroptosis and Alleviating Hypoxia. Small 20(26):e2306916. https:\/\/doi.org\/10.1002\/smll.202306916","journal-title":"Small"},{"key":"11707_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122675","volume":"311","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zhang N, Xing J et al (2024) In situ hydrogel based on Cu-Fe(3)O(4) nanoclusters exploits oxidative stress and the ferroptosis\/cuproptosis pathway for chemodynamic therapy. Biomaterials 311:122675. https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122675","journal-title":"Biomaterials"},{"issue":"7","key":"11707_CR51","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202403160R","volume":"39","author":"R Huang","year":"2025","unstructured":"Huang R, Xu R, Shi J et al (2025) Artesunate induces ferroptosis in osteosarcoma through NCOA4-mediated ferritinophagy. Faseb j 39(7):e70488. https:\/\/doi.org\/10.1096\/fj.202403160R","journal-title":"Faseb j"},{"issue":"1","key":"11707_CR52","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12885-024-11951-1","volume":"24","author":"F Zhang","year":"2024","unstructured":"Zhang F, Hao Y, Yang N et al (2024) Oridonin-induced ferroptosis and apoptosis: a dual approach to suppress the growth of osteosarcoma cells. BMC Cancer 24(1):198. https:\/\/doi.org\/10.1186\/s12885-024-11951-1","journal-title":"BMC Cancer"},{"key":"11707_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156912","volume":"144","author":"L Zhang","year":"2025","unstructured":"Zhang L, Luo D, Ren H et al (2025) Brusatol induced ferroptosis in osteosarcoma cells by modulating the Keap1\/Nrf2\/SLC7A11 signaling pathway. Phytomedicine 144:156912. https:\/\/doi.org\/10.1016\/j.phymed.2025.156912","journal-title":"Phytomedicine"},{"key":"11707_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110602","volume":"382","author":"Z Liu","year":"2023","unstructured":"Liu Z, Wang X, Li J et al (2023) Gambogenic acid induces cell death in human osteosarcoma through altering iron metabolism, disturbing the redox balance, and activating the P53 signaling pathway. Chem Biol Interact 382:110602. https:\/\/doi.org\/10.1016\/j.cbi.2023.110602","journal-title":"Chem Biol Interact"},{"key":"11707_CR55","doi-asserted-by":"publisher","first-page":"5192271","DOI":"10.1155\/2021\/51922717","volume":"2021","author":"Z Tang","year":"2021","unstructured":"Tang Z, Dong H, Li T et al (2021) The Synergistic Reducing Drug Resistance Effect of Cisplatin and Ursolic Acid on Osteosarcoma through a Multistep Mechanism Involving Ferritinophagy. Oxid Med Cell Longev 2021:5192271. https:\/\/doi.org\/10.1155\/2021\/51922717","journal-title":"Oxid Med Cell Longev"},{"key":"11707_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2024.106488","author":"Z Chen","year":"2024","unstructured":"Chen Z, Ni RH, Hu YY et al (2024) A natural protopanaxatriol from Panax notoginseng enhances osteosarcoma sensitivity to ferroptosis via ASCL4 upregulation. J Funct Foods. https:\/\/doi.org\/10.1016\/j.jff.2024.106488","journal-title":"J Funct Foods"},{"key":"11707_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103460","volume":"79","author":"Q Zou","year":"2025","unstructured":"Zou Q, Zhou X, Lai J et al (2025) Targeting p62 by sulforaphane promotes autolysosomal degradation of SLC7A11, inducing ferroptosis for osteosarcoma treatment. Redox Biol 79:103460. https:\/\/doi.org\/10.1016\/j.redox.2024.103460","journal-title":"Redox Biol"},{"key":"11707_CR58","doi-asserted-by":"publisher","first-page":"5021983","DOI":"10.1155\/2020\/5021983","volume":"2020","author":"H Lv","year":"2020","unstructured":"Lv H, Zhen C, Liu J, Shang P (2020) \u03b2-Phenethyl isothiocyanate induces cell death in human osteosarcoma through altering iron metabolism, disturbing the redox balance, and activating the MAPK signaling pathway. Oxid Med Cell Longev 2020:5021983. https:\/\/doi.org\/10.1155\/2020\/5021983","journal-title":"Oxid Med Cell Longev"},{"key":"11707_CR59","doi-asserted-by":"publisher","first-page":"1592862","DOI":"10.3389\/fonc.2025.1592862","volume":"15","author":"G Yang","year":"2025","unstructured":"Yang G, Li F, Hu X et al (2025) Exploration of the role and mechanism of Rhizoma Paridis total saponins in osteosarcoma based on SPI1\/LCN2-mediated ferroptosis. Front Oncol 15:1592862. https:\/\/doi.org\/10.3389\/fonc.2025.1592862","journal-title":"Front Oncol"},{"issue":"1","key":"11707_CR60","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/00498254.2025.2598384","volume":"56","author":"B Zhang","year":"2026","unstructured":"Zhang B, Yu X, Yan Y, Tang K (2026) \u03b1-Hederin inhibits osteosarcoma progression by triggering ferroptosis and disrupting mitochondrial function via PI3K\/AKT signalling. Xenobiotica 56(1):53\u201365. https:\/\/doi.org\/10.1080\/00498254.2025.2598384","journal-title":"Xenobiotica"},{"key":"11707_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176009","volume":"957","author":"J Nie","year":"2023","unstructured":"Nie J, Ling Y, Jin M et al (2023) Butyrate enhances erastin-induced ferroptosis of osteosarcoma cells via regulating ATF3\/SLC7A11 pathway. Eur J Pharmacol 957:176009. https:\/\/doi.org\/10.1016\/j.ejphar.2023.176009","journal-title":"Eur J Pharmacol"},{"issue":"23","key":"11707_CR62","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1177\/15353702231220670","volume":"248","author":"C Yuan","year":"2023","unstructured":"Yuan C, Fan R, Zhu K et al (2023) Curcumin induces ferroptosis and apoptosis in osteosarcoma cells by regulating Nrf2\/GPX4 signaling pathway. Exp Biol Med (Maywood) 248(23):2183\u20132197. https:\/\/doi.org\/10.1177\/15353702231220670","journal-title":"Exp Biol Med (Maywood)"},{"key":"11707_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.120055","volume":"350","author":"D Xiang","year":"2025","unstructured":"Xiang D, Zhang X, Xue X et al (2025) Marsdenia tenacissima extract accelerates ferroptosis of osteosarcoma cells by upregulating HO-1 and activating mitophagy. J Ethnopharmacol 350:120055. https:\/\/doi.org\/10.1016\/j.jep.2025.120055","journal-title":"J Ethnopharmacol"},{"key":"11707_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/cimb47010021","author":"A Cimmino","year":"2024","unstructured":"Cimmino A, Gioia M, Clementi ME et al (2024) Polydatin-induced shift of redox balance and its anti-cancer impact on human osteosarcoma cells. Curr Issues Mol Biol. https:\/\/doi.org\/10.3390\/cimb47010021","journal-title":"Curr Issues Mol Biol"},{"key":"11707_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2025.102745","volume":"93","author":"Z Ma","year":"2025","unstructured":"Ma Z, Wang Y, Zhang X et al (2025) Curculigoside exhibits multiple therapeutic efficacy to induce apoptosis and ferroptosis in osteosarcoma via modulation of ROS and tumor microenvironment. Tissue Cell 93:102745. https:\/\/doi.org\/10.1016\/j.tice.2025.102745","journal-title":"Tissue Cell"},{"key":"11707_CR66","doi-asserted-by":"publisher","first-page":"9390611","DOI":"10.1155\/2022\/9390611","volume":"2022","author":"H Zhan","year":"2022","unstructured":"Zhan H, Xiao J, Wang P et al (2022) Exosomal CTCF Confers Cisplatin Resistance in Osteosarcoma by Promoting Autophagy via the IGF2-AS\/miR-579-3p\/MSH6 Axis. J Oncol 2022:9390611. https:\/\/doi.org\/10.1155\/2022\/9390611","journal-title":"J Oncol"},{"key":"11707_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108373","volume":"244","author":"I Costa","year":"2023","unstructured":"Costa I, Barbosa DJ, Benfeito S et al (2023) Molecular mechanisms of ferroptosis and their involvement in brain diseases. Pharmacol Ther 244:108373. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108373","journal-title":"Pharmacol Ther"},{"issue":"1","key":"11707_CR68","doi-asserted-by":"publisher","first-page":"26425","DOI":"10.1038\/s41598-025-09568-w","volume":"15","author":"P Wang","year":"2025","unstructured":"Wang P, Xiao J, Zeng J et al (2025) PSAT1 inhibits ferroptosis in osteosarcoma cells by activating the Xct\/GPX4 signaling axis. Sci Rep 15(1):26425. https:\/\/doi.org\/10.1038\/s41598-025-09568-w","journal-title":"Sci Rep"},{"issue":"7","key":"11707_CR69","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41419-023-05966-y","volume":"14","author":"W Guo","year":"2023","unstructured":"Guo W, Wang X, Lu B et al (2023) Super-enhancer-driven MLX mediates redox balance maintenance via SLC7A11 in osteosarcoma. Cell Death Dis 14(7):439. https:\/\/doi.org\/10.1038\/s41419-023-05966-y","journal-title":"Cell Death Dis"},{"key":"11707_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2026.124043","volume":"330","author":"M Li","year":"2026","unstructured":"Li M, He L, Wang Z et al (2026) Amplified ferroptosis and immunomodulation triggered by NIR-II photothermal-controllable CRISPR\/Cas9 nanoplatform to treat osteosarcoma and prevent postsurgical implant-associated infections. Biomaterials 330:124043. https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124043","journal-title":"Biomaterials"},{"issue":"6","key":"11707_CR71","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41573-025-01145-0","volume":"24","author":"DD Zhang","year":"2025","unstructured":"Zhang DD (2025) Thirty years of NRF2: advances and therapeutic challenges. Nat Rev Drug Discov 24(6):421\u2013444. https:\/\/doi.org\/10.1038\/s41573-025-01145-0","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"11707_CR72","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41420-024-02205-x","volume":"10","author":"JJ Zhang","year":"2024","unstructured":"Zhang JJ, Ni P, Song Y et al (2024) Effective protective mechanisms of HO-1 in diabetic complications: a narrative review. Cell Death Discov 10(1):433. https:\/\/doi.org\/10.1038\/s41420-024-02205-x","journal-title":"Cell Death Discov"},{"key":"11707_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076189","author":"S Horii","year":"2023","unstructured":"Horii S, Mori S, Ogata R et al (2023) 5-Aminolevrinic Acid Exhibits Dual Effects on Stemness in Human Sarcoma Cell Lines under Dark Conditions. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24076189","journal-title":"Int J Mol Sci"},{"issue":"38","key":"11707_CR74","doi-asserted-by":"publisher","first-page":"44689","DOI":"10.1021\/acsami.3c07379","volume":"15","author":"K Yu","year":"2023","unstructured":"Yu K, Chen Y, Zhang L et al (2023) Cancer-Erythrocyte Membrane-Mimicking Fe(3)O(4) Nanoparticles and DHJS for Ferroptosis\/Immunotherapy Synergism in Tumors. ACS Appl Mater Interfaces 15(38):44689\u201344710. https:\/\/doi.org\/10.1021\/acsami.3c07379","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"11707_CR75","doi-asserted-by":"publisher","first-page":"30197","DOI":"10.1038\/s41598-025-13324-5","volume":"15","author":"Q Qin","year":"2025","unstructured":"Qin Q, Zhang H, Lai M et al (2025) Sulfasalazine induces ferroptosis in osteosarcomas by regulating Nrf2\/SLC7A11\/GPX4 signaling axis. Sci Rep 15(1):30197. https:\/\/doi.org\/10.1038\/s41598-025-13324-5","journal-title":"Sci Rep"},{"issue":"1","key":"11707_CR76","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","volume":"8","author":"H Wang","year":"2023","unstructured":"Wang H, Guo M, Wei H, Chen Y (2023) Targeting p53 pathways: mechanisms, structures, and advances in therapy. Signal Transduct Target Ther 8(1):92. https:\/\/doi.org\/10.1038\/s41392-023-01347-1","journal-title":"Signal Transduct Target Ther"},{"key":"11707_CR77","doi-asserted-by":"publisher","first-page":"32819","DOI":"10.34172\/bi.32819","volume":"16","author":"M Ebrahimnezhad","year":"2026","unstructured":"Ebrahimnezhad M, Valizadeh A, Yousefi B, Shanehbandi D (2026) Celastrol overcomes 5-fluorouracil resistance in osteosarcoma cells through p53-mediated apoptotic pathway modulation and P-glycoprotein inhibition: A comprehensive mechanistic study. Bioimpacts 16:32819. https:\/\/doi.org\/10.34172\/bi.32819","journal-title":"Bioimpacts"},{"key":"11707_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112672","volume":"139","author":"H Xiao","year":"2024","unstructured":"Xiao H, Jiang N, Zhang H et al (2024) Inhibitors of APE1 redox and ATM synergistically sensitize osteosarcoma cells to ionizing radiation by inducing ferroptosis. Int Immunopharmacol 139:112672. https:\/\/doi.org\/10.1016\/j.intimp.2024.112672","journal-title":"Int Immunopharmacol"},{"key":"11707_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/proteomes13010006","volume":"13","author":"S Gupta","year":"2025","unstructured":"Gupta S, Silveira DA, Mombach JCM, Hashimoto RF (2025) DNA damage-induced ferroptosis: a boolean model regulating p53 and non-coding RNAs in drug resistance. Proteomes 13:1. https:\/\/doi.org\/10.3390\/proteomes13010006","journal-title":"Proteomes"},{"issue":"1","key":"11707_CR80","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12964-023-01170-9","volume":"21","author":"X Wang","year":"2023","unstructured":"Wang X, Tan X, Zhang J et al (2023) The emerging roles of MAPK-AMPK in ferroptosis regulatory network. Cell Commun Signal 21(1):200. https:\/\/doi.org\/10.1186\/s12964-023-01170-9","journal-title":"Cell Commun Signal"},{"issue":"1","key":"11707_CR81","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13046-024-02949-5","volume":"43","author":"Y Hu","year":"2024","unstructured":"Hu Y, Dong Z, Liu K (2024) Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery. J Exp Clin Cancer Res 43(1):23. https:\/\/doi.org\/10.1186\/s13046-024-02949-5","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"11707_CR82","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12935-025-03681-6","volume":"25","author":"Y Dai","year":"2025","unstructured":"Dai Y, Cui C, Jiao D, Zhu X (2025) JAK\/STAT signaling as a key regulator of ferroptosis: mechanisms and therapeutic potentials in cancer and diseases. Cancer Cell Int 25(1):83. https:\/\/doi.org\/10.1186\/s12935-025-03681-6","journal-title":"Cancer Cell Int"},{"key":"11707_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2023.100490","volume":"41","author":"S Xia","year":"2023","unstructured":"Xia S, Liang Y, Shen Y et al (2023) MAT2A inhibits the ferroptosis in osteosarcoma progression regulated by miR-26b-5p. J Bone Oncol 41:100490. https:\/\/doi.org\/10.1016\/j.jbo.2023.100490","journal-title":"J Bone Oncol"},{"key":"11707_CR84","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.freeradbiomed.2026.03.046","volume":"249","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, Meng T, Chen L et al (2026) METTL3-mediated m(6)A modification contributes to anlotinib resistance in osteosarcoma by regulating ferroptosis via the circFAM120B\/miR-330-3p\/PRKDC axis. Free Radic Biol Med 249:409\u2013423","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"11707_CR85","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41419-024-06503-1","volume":"15","author":"C Han","year":"2024","unstructured":"Han C, Ge M, Xing P et al (2024) Cystine deprivation triggers CD36-mediated ferroptosis and dysfunction of tumor infiltrating CD8(+) T cells. Cell Death Dis 15(2):145","journal-title":"Cell Death Dis"},{"issue":"1","key":"11707_CR86","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00018-025-05982-5","volume":"83","author":"S Toyokuni","year":"2025","unstructured":"Toyokuni S, Kong Y, Maeda Y et al (2025) Ferroptosis and cancer: when iron turns against tumors. Cell Mol Life Sci 83(1):16. https:\/\/doi.org\/10.1007\/s00018-025-05982-5","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"11707_CR87","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.240391","volume":"15","author":"JH Choi","year":"2025","unstructured":"Choi JH, Kagan JC (2025) Oxidized phospholipid damage signals as modulators of immunity. Open Biol 15(7):240391. https:\/\/doi.org\/10.1098\/rsob.240391","journal-title":"Open Biol"},{"issue":"5","key":"11707_CR88","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41577-021-00618-8","volume":"22","author":"D Zhivaki","year":"2022","unstructured":"Zhivaki D, Kagan JC (2022) Innate immune detection of lipid oxidation as a threat assessment strategy. Nat Rev Immunol 22(5):322\u2013330. https:\/\/doi.org\/10.1038\/s41577-021-00618-8","journal-title":"Nat Rev Immunol"},{"key":"11707_CR89","doi-asserted-by":"publisher","first-page":"1119369","DOI":"10.3389\/fonc.2023.1119369","volume":"13","author":"H Cai","year":"2023","unstructured":"Cai H, Ren Y, Chen S et al (2023) Ferroptosis and tumor immunotherapy: A promising combination therapy for tumors. Front Oncol 13:1119369. https:\/\/doi.org\/10.3389\/fonc.2023.1119369","journal-title":"Front Oncol"},{"issue":"1","key":"11707_CR90","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1038\/s41467-022-31218-2","volume":"13","author":"B Wiernicki","year":"2022","unstructured":"Wiernicki B, Maschalidi S, Pinney J et al (2022) Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity. Nat Commun 13(1):3676. https:\/\/doi.org\/10.1038\/s41467-022-31218-2","journal-title":"Nat Commun"},{"issue":"1","key":"11707_CR91","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41419-025-08204-9","volume":"16","author":"J Liu","year":"2025","unstructured":"Liu J, Dong R, Yuan B et al (2025) Immune cells dying from ferroptosis: mechanisms and therapeutic opportunities. Cell Death Dis 16(1):878. https:\/\/doi.org\/10.1038\/s41419-025-08204-9","journal-title":"Cell Death Dis"},{"key":"11707_CR92","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/nu16081201","volume":"16","author":"D Wendlocha","year":"2024","unstructured":"Wendlocha D, Kubina R, Krzykawski K, Mielczarek-Palacz A (2024) Selected flavonols targeting cell death pathways in cancer therapy: the latest achievements in research on apoptosis, autophagy, necroptosis, pyroptosis, ferroptosis, and cuproptosis. Nutrients 16:8. https:\/\/doi.org\/10.3390\/nu16081201","journal-title":"Nutrients"},{"issue":"1","key":"11707_CR93","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1186\/s12967-023-04682-7","volume":"21","author":"M Luo","year":"2023","unstructured":"Luo M, Su Z, Gao H et al (2023) Cirsiliol induces autophagy and mitochondrial apoptosis through the AKT\/FOXO1 axis and influences methotrexate resistance in osteosarcoma. J Transl Med 21(1):907. https:\/\/doi.org\/10.1186\/s12967-023-04682-7","journal-title":"J Transl Med"},{"issue":"2","key":"11707_CR94","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.tjnut.2024.11.015","volume":"155","author":"F Tian","year":"2025","unstructured":"Tian F, Sun S, Ge Z et al (2025) Understanding the Anticancer Effects of Phytochemicals: From Molecular Docking to Anticarcinogenic Signaling. J Nutr 155(2):431\u2013444. https:\/\/doi.org\/10.1016\/j.tjnut.2024.11.015","journal-title":"J Nutr"},{"key":"11707_CR95","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/nu15041031","volume":"15","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Wang D, Yan W (2023) Treatment Effects of Natural Products on Inflammatory Bowel Disease In Vivo and Their Mechanisms: Based on Animal Experiments. Nutrients 15:4. https:\/\/doi.org\/10.3390\/nu15041031","journal-title":"Nutrients"},{"key":"11707_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2025.100699","volume":"53","author":"X Yuan","year":"2025","unstructured":"Yuan X, Li J, Yu B et al (2025) Demethylzeylasteral inhibits proliferation and metastasis of osteosarcoma cells by modulating the PI3K\/AKT\/Autophagy pathways. J Bone Oncol 53:100699. https:\/\/doi.org\/10.1016\/j.jbo.2025.100699","journal-title":"J Bone Oncol"},{"key":"11707_CR97","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/molecules29163886","volume":"29","author":"L Wen","year":"2024","unstructured":"Wen L, Chan BC, Qiu MH et al (2024) Artemisinin and Its Derivatives as Potential Anticancer Agents. Molecules 29:16. https:\/\/doi.org\/10.3390\/molecules29163886","journal-title":"Molecules"},{"key":"11707_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107526","volume":"210","author":"X Liu","year":"2024","unstructured":"Liu X, Cai Y, Zhang Y et al (2024) Artesunate: A potential drug for the prevention and treatment from hepatitis to hepatocellular carcinoma. Pharmacol Res 210:107526. https:\/\/doi.org\/10.1016\/j.phrs.2024.107526","journal-title":"Pharmacol Res"},{"key":"11707_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117232","volume":"178","author":"B Fan","year":"2024","unstructured":"Fan B, Guo Q, Wang S (2024) The application of alkaloids in ferroptosis: A review. Biomed Pharmacother 178:117232. https:\/\/doi.org\/10.1016\/j.biopha.2024.117232","journal-title":"Biomed Pharmacother"},{"key":"11707_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108557","volume":"161","author":"L Yu","year":"2025","unstructured":"Yu L, Bi K, Gu J et al (2025) Harmine exerts anticancer effects through the ROS\/p38 axis to induce autophagy and apoptosis in osteosarcoma. Bioorg Chem 161:108557. https:\/\/doi.org\/10.1016\/j.bioorg.2025.108557","journal-title":"Bioorg Chem"},{"key":"11707_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2024.106339","volume":"119","author":"X Liu","year":"2024","unstructured":"Liu X, Ye C, Feng J et al (2024) Lycorine combined with cisplatin synergistically inhibited osteosarcoma cells growth and metastasis by suppressing Wnt\/\u03b2-catenin and STAT3 signaling pathways. J Funct Foods 119:106339. https:\/\/doi.org\/10.1016\/j.jff.2024.106339","journal-title":"J Funct Foods"},{"key":"11707_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2025.118325","volume":"129","author":"F Yu","year":"2025","unstructured":"Yu F, Li S, Li B et al (2025) Recent research progress of \u03b2-carbolines as privileged scaffold in the discovery of anticancer agent (2019\u20132024). Bioorg Med Chem 129:118325. https:\/\/doi.org\/10.1016\/j.bmc.2025.118325","journal-title":"Bioorg Med Chem"},{"key":"11707_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106643","volume":"138","author":"X Shen","year":"2023","unstructured":"Shen X, Liang X, He C et al (2023) Structural and pharmacological diversity of 1,4-naphthoquinone glycosides in recent 20 years. Bioorg Chem 138:106643. https:\/\/doi.org\/10.1016\/j.bioorg.2023.106643","journal-title":"Bioorg Chem"},{"issue":"1","key":"11707_CR104","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/ptr.8042","volume":"38","author":"D Rizwan","year":"2024","unstructured":"Rizwan D, Masoodi FA (2024) Brassica-derived isothiocyanates as anticancer therapeutic agents and their nanodelivery. Phytother Res 38(1):331\u2013348. https:\/\/doi.org\/10.1002\/ptr.8042","journal-title":"Phytother Res"},{"issue":"8","key":"11707_CR105","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/s41401-020-0376-8","volume":"41","author":"HH Lv","year":"2020","unstructured":"Lv HH, Zhen CX, Liu JY, Shang P (2020) PEITC triggers multiple forms of cell death by GSH-iron-ROS regulation in K7M2 murine osteosarcoma cells. Acta Pharmacol Sin 41(8):1119\u20131132. https:\/\/doi.org\/10.1038\/s41401-020-0376-8","journal-title":"Acta Pharmacol Sin"},{"key":"11707_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111202","volume":"136","author":"H Lin","year":"2021","unstructured":"Lin H, Chen X, Zhang C et al (2021) EF24 induces ferroptosis in osteosarcoma cells through HMOX1. Biomed Pharmacother 136:111202. https:\/\/doi.org\/10.1016\/j.biopha.2020.111202","journal-title":"Biomed Pharmacother"},{"key":"11707_CR107","doi-asserted-by":"publisher","first-page":"1441105","DOI":"10.3389\/fphar.2024.1441105","volume":"15","author":"D Xie","year":"2024","unstructured":"Xie D, Jiang Y, Wang H et al (2024) Formononetin triggers ferroptosis in triple-negative breast cancer cells by regulating the mTORC1\/SREBP1\/SCD1 pathway. Front Pharmacol 15:1441105. https:\/\/doi.org\/10.3389\/fphar.2024.1441105","journal-title":"Front Pharmacol"},{"issue":"1","key":"11707_CR108","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12943-025-02416-5","volume":"24","author":"P Song","year":"2025","unstructured":"Song P, Liu T, Zhang Y et al (2025) Traditional Chinese medicine in the treatment of breast Cancer. Mol Cancer 24(1):209. https:\/\/doi.org\/10.1186\/s12943-025-02416-5","journal-title":"Mol Cancer"},{"issue":"1","key":"11707_CR109","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-03742-2","volume":"16","author":"X-y Chen","year":"2025","unstructured":"Chen X-y, Yang X-q, Wang M-y (2025) PH responsive hydrogel nanocomposites for targeted shikonin delivery enhance anti PDL1 immunotherapy in osteosarcoma. Discov Oncol 16(1):1856. https:\/\/doi.org\/10.1007\/s12672-025-03742-2","journal-title":"Discov Oncol"},{"issue":"9","key":"11707_CR110","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.3109\/10717544.2016.1162875","volume":"23","author":"L Wang","year":"2016","unstructured":"Wang L, Wang W, Rui Z, Zhou D (2016) The effective combination therapy against human osteosarcoma: doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system. Drug Deliv 23(9):3200\u20133208. https:\/\/doi.org\/10.3109\/10717544.2016.1162875","journal-title":"Drug Deliv"},{"issue":"7","key":"11707_CR111","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.3390\/ph3072322","volume":"3","author":"Q Li","year":"2010","unstructured":"Li Q, Weina P (2010) Artesunate: The Best Drug in the Treatment of Severe and Complicated Malaria. Pharmaceuticals (Basel) 3(7):2322\u20132332. https:\/\/doi.org\/10.3390\/ph3072322","journal-title":"Pharmaceuticals (Basel)"},{"key":"11707_CR112","unstructured":"Evaluation of Curcumin Formulation, and Ashwagandha Root Powder Extract in the Management of Advanced High Grade Osteosarcoma. In: Pharmanza Herbals Pvt L, ed2008."},{"issue":"1","key":"11707_CR113","doi-asserted-by":"publisher","DOI":"10.1186\/s12645-024-00247-5","volume":"15","author":"X Lu","year":"2024","unstructured":"Lu X, Zhang P, Li J et al (2024) The effect of doxorubicin curcumin co-loaded lipid nanoparticles and doxorubicin on osteosarcoma before surgery. Cancer Nanotechnol 15(1):11. https:\/\/doi.org\/10.1186\/s12645-024-00247-5","journal-title":"Cancer Nanotechnol"},{"issue":"22","key":"11707_CR114","doi-asserted-by":"publisher","first-page":"4459","DOI":"10.1007\/s00018-020-03536-5","volume":"77","author":"A Kirtonia","year":"2020","unstructured":"Kirtonia A, Sethi G, Garg M (2020) The multifaceted role of reactive oxygen species in tumorigenesis. Cell Mol Life Sci 77(22):4459\u20134483. https:\/\/doi.org\/10.1007\/s00018-020-03536-5","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"11707_CR115","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-025-10459-6","volume":"52","author":"S Biswal","year":"2025","unstructured":"Biswal S, Sahoo SK, Biswal BK (2025) Shikonin a potent phytotherapeutic: a comprehensive review on metabolic reprogramming to overcome drug resistance in cancer. Mol Biol Rep 52(1):347. https:\/\/doi.org\/10.1007\/s11033-025-10459-6","journal-title":"Mol Biol Rep"},{"issue":"2","key":"11707_CR116","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1208\/s12249-013-9966-9","volume":"14","author":"H Xiong","year":"2013","unstructured":"Xiong H, Yu LX, Qu H (2013) Batch-to-batch quality consistency evaluation of botanical drug products using multivariate statistical analysis of the chromatographic fingerprint. AAPS PharmSciTech 14(2):802\u2013810. https:\/\/doi.org\/10.1208\/s12249-013-9966-9","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"11707_CR117","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1021\/acs.jnatprod.9b00949","volume":"83","author":"C Wu","year":"2020","unstructured":"Wu C, Lee SL, Taylor C et al (2020) Scientific and regulatory approach to botanical drug development: a U.S. FDA perspective. J Nat Prod 83(2):552\u2013562. https:\/\/doi.org\/10.1021\/acs.jnatprod.9b00949","journal-title":"J Nat Prod"},{"key":"11707_CR118","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.2147\/ijn.S401570","volume":"18","author":"C Yan","year":"2023","unstructured":"Yan C, Li Q, Sun Q et al (2023) Promising Nanomedicines of Shikonin for Cancer Therapy. Int J Nanomed 18:1195\u20131218. https:\/\/doi.org\/10.2147\/ijn.S401570","journal-title":"Int J Nanomed"},{"key":"11707_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153805","volume":"94","author":"Q Sun","year":"2022","unstructured":"Sun Q, Gong T, Liu M et al (2022) Shikonin, a naphthalene ingredient: therapeutic actions, pharmacokinetics, toxicology, clinical trials and pharmaceutical researches. Phytomedicine 94:153805. https:\/\/doi.org\/10.1016\/j.phymed.2021.153805","journal-title":"Phytomedicine"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11707-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11707-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11707-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:04:32Z","timestamp":1793858672000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11707-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":119,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["11707"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11707-y","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"5 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Affiliation of author Yuwen Dai is updated.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}